Tradestie Institutional Equity Comparison Engine

SNOA vs FEED โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SNOA Overall Edge

SNOA Captures Institutional Edge (2โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) driven by superior Valuation, Growth & Margin while FEED counters with relative strength in Momentum & Technical. Fundamentally, SNOA trades at 46.1x Forward P/E with -3.3% operating margin (+28.0% YoY revenue) versus FEED at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, SNOA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against FEED sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SNOA
SNOA 46.1x vs FEED N/M Fwd P/E
Growth & Margin Winner SNOA
Op Margin -3.3% vs N/A ยท YoY +28.0% vs N/A
Momentum & Technical Winner FEED
1Y -78.4% vs -75.3% ยท 52W Pos 0% vs 13%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SNOA NASDAQ
Sonoma Pharmaceuticals, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.72
-10.83% 1D
Market Cap $4.1M
1M Return -37.22%
1Y Return -78.38%
Forward P/E 46.1x
Unified AI Score
36.4 / 100 SELL
Tech 25.0 Fund 37.0 Flow 50.0 Mom 34.0
FEED US Equity
FEED
Institutional Equity
$1.03
-69.25% 1D
Market Cap N/A
1M Return +135.7%
1Y Return -75.27%
Forward P/E N/M
Unified AI Score
37.1 / 100 SELL
Tech 15.0 Fund 28.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SNOA -78.38% FEED -75.27% Spread: +10.53 pp (SNOA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SNOA TTM Op. Margin: -3.3% FEED TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SNOA vs FEED. Trailing 12-month operating profitability (SNOA -3.3% vs FEED N/A) and valuation multiples (SNOA 46.1x vs FEED N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SNOA (8) vs FEED (2)
Institutional Metric SNOA FEED Criterion Row Winner
Market Capitalization Scale $4.1M N/A Larger Scale SNOA
Trailing P/E Ratio Valuation 46.1x N/M Lower Multiple SNOA
Forward P/E Ratio Valuation 46.1x N/M Lower Multiple SNOA
Revenue Growth (YoY) Growth +28.0% N/A Higher Growth SNOA
Operating Margin (TTM) Profitability -3.3% N/A Higher Margin SNOA
Net Profit Margin Profitability -7.6% N/A Higher Margin SNOA
Return on Equity (ROE) Capital Efficiency -34.5% N/A Higher ROE SNOA
52-Week Range Position Momentum 0% ($1โ€“$4) 13% ($0โ€“$6) Stronger Trend FEED
Beta / 30D Volatility Risk Regime 1.59ฮฒ ยท 92% Vol -6.40ฮฒ ยท 3942% Vol Lower Realized Risk SNOA
Unified Institutional Score Composite Signal 36.4 / 100 (SELL) 37.1 / 100 (SELL) Higher Composite FEED

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SNOA vs FEED Buy Guide
SNOA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SNOA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FEED UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FEED Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SNOA nor FEED registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.